| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |